1
Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT
Condition(s):X-linked Hypophosphatemia (XLH)Last Updated:May 5, 2021Not yet recruiting
X-linked Hypophosphatemia: 55 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
X-linked Hypophosphatemia and FGF21
Condition(s):X-linked HypophosphatemiaLast Updated:October 27, 2020Completed
3
Registry for Patients With X-Linked Hypophosphatemia
Condition(s):X-Linked HypophosphatemiaLast Updated:September 22, 2022Recruiting
4
Dental Implants in Patients With X-linked Hypophosphatemia
Condition(s):X-linked HypophosphatemiaLast Updated:June 30, 2022Recruiting
5
Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
Condition(s):X-linked HypophosphatemiaLast Updated:July 18, 2019Completed
6
Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)
Condition(s):X-linked HypophosphatemiaLast Updated:February 5, 2021Completed
7
Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia
Condition(s):X-linked HypophosphatemiaLast Updated:January 30, 2019Unknown status
8
Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)
Condition(s):X-linked HypophosphatemiaLast Updated:December 23, 2019Completed
9
Efficacy and Safety of Burosumab (KRN23) Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Condition(s):X-Linked HypophosphatemiaLast Updated:January 23, 2020Completed
10
Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
Condition(s):X-Linked HypophosphatemiaLast Updated:March 31, 2020Completed